Durham, N.C. – Serenex, Inc., an integrated drug discovery and development company, announced today that it has secured $31 million in financing. The round comprises a $26 million Series D private placement of preferred stock and a $5 million working capital debt facility. The round was oversubscribed and included new investors Cornell Capital Partners, Pearl Street Ventures, MC Life Science Ventures and Pac-Link Bio Venture Capital as well as existing investors Ritchie Capital, Intersouth Partners, Lilly Ventures, Mediphase Venture Partners, Takeda Research Investment and Seaflower Ventures. (more…)
DULUTH, GA—Cellutions, which is developing medical devices to treat cellulite, has raised a $7 million second round led by Versant Ventures with return investors Acculitive, Medical Ventures, Carlyle Venture Partners and SV Life Sciences participating. (more…)
RESEARCH TRIANGLE PARK, N.C.–CivaTech Oncology, Inc., an early stage company developing a novel medical device for the treatment of prostate cancer, has raised $800,000 in an oversubscribed private financing. (more…)
RESEARCH TRIANGLE PARK, N.C.– Norris Tolson was selected President and CEO of the North Carolina Biotechnology Center by its board of directors, effective July 2. (more…)
CHARLESTON, SC—Argolyn Bioscience Inc., which is developing treatments for psychosis, pain and other disorders, has raised a $15.8 million first round co-led by Intersouth Partners and Quaker BioVentures. Amgen Ventures also participated in what is one of the largest biotech deals in SC history. (more…)
Arbovax has closed on the first half of its $1.5 million angel investment round. (more…)
RALEIGH, NC—Respirics Inc. has closed a $2.5 million first round from two angel investor groups, Catalysta Ventures and Research Triangle Ventures and several new angel investors. (more…)
Miami, FL– Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) today announced that Shire plc has exercised its option under agreements with Noven to acquire the exclusive development rights to a new transdermal patch for ADHD to be formulated by Noven. In connection with this exercise, Noven received a $5.9 million milestone payment from Shire. (more…)
ATLANTA, GA–Sciele Pharma, Inc. (NASDAQ:SCRX) today announced the launch of Prenate DHA, a prescription multivitamin nutritional supplement with essential minerals, Omega-3 fatty acids/DHA and Metafolin, indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and non-lactating mothers. (more…)
Atlanta, GA — RFS Pharma, LLC, and Genoscience Pharma today announced the formation of a drug discovery joint venture to develop promising protease inhibitors for the treatment of lifethreatening viral infections. (more…)
